Pharmasyntez was one of the participants of the collective booth of Russian pharmaceutical manufacturers of the Russian Export Center. The Company’s representatives introduced the participants of the event to the portfolio of drug products manufactured by the company, antineoplastic therapy drugs (45 names) manufactured by Pharmasyntez-Nord JSC in particular.

According to Pharmasyntez representatives, such events are useful, first of all, because they bring together in one place both private market players and key state structures, thus allowing to establish effective dialogue and interaction. In addition, participation in the exhibition helps to establish business ties with pharmaceutical distributors and to present the medicines produced to healthcare professionals from the EAEU countries.

"Uzbekistan is interesting for our company, first of all, due to the rates of pharmaceutical industry development, rapid growth of pharmaceutical market capacity as well as the increase in the quality and volume of public procurement of medicines. Here at Innoprom, we have already held negotiations with the Pharmaceutical Industry Development Agency of Uzbekistan on possible formats of interaction and further cooperation," said Eduard Voskoboy, Sales Manager of the Pharmasyntez Group in CIS and ASEAN countries.